Publications Office of the EU
Acquisition of brexukabtagen autoleuseel (Tecartus® 0.4 to 2 × 108 cells solution for infusion, dispersion) - EU tenders
DisplayCustomHeader
MyPortal
Language Selector
English
BasketSummary
Procurement Detail Actions Portlet

Utilities

Procurement Detail Actions Portlet
OP Portal - Procurement - Details

This page contains content generated automatically to improve findability and accessibility

- indicates text translated automatically in your browsing language

Acquisition of brexukabtagen autoleuseel (Tecartus® 0.4 to 2 × 108 cells solution for infusion, dispersion) Text automatically translated in your browsing language Automatically translated

Overview
  • Awarded
    05/12/2024
  • Today
    15/01/2025
Status
Awarded
Type of contract
Supplies
Subject for Renewal
Yes
Buyer
HUS Group, the joint authority for Helsinki and Uusimaa
Place of performance
NUTS code: Multiple place of performance
Location of buyer
NUTS code: FI1B1 Helsinki-Uusimaa
Business sector (Main CPV)
33600000 Pharmaceutical products
Total estimated contract value (excluding VAT)
Not available
Total final contract value (excluding VAT)
6,000,000.00 EUR
Procedure details
Tender reference number
Not available
Description

Acquisition of Brexukabtagen autoleuseel (Tecartus ® 0.4 -2 × 108 cells solution for infusion, dispersion) for use in fit adults (WHO 0 – 1) with relapsed or refractory mantle cell lymphoma treated with at least two prior lines of treatment including Bruton's tyrosine kinase (BTK) inhibitor and in fit patients (ECOG performance class 0-1) with relapsed or refractory precursor B cell acute lymphoblastic leukaemia (ALL) aged 26 years and above, in accordance with the Summary of Product Characteristics and the recommendations of the Council for Health Care Services (Palko) (15.12.2021 and 7.11.2024). Text automatically translated in your browsing language Automatically translated

Submission Method
Not available
Tenders may be submitted
Not available
Information about a public contract, a framework agreement or a dynamic purchasing system (DPS)
Not available
Conditions for opening tenders (date)
Not available
Buyers
Pirkanmaan hyvinvointialue
Pohjois-Pohjanmaan hyvinvointialue
Pohjois-Pohjanmaan hyvinvointialue
Pirkanmaan hyvinvointialue
Place of performance
FI Suomi/Finland
Any country
CPV code

33600000 - Pharmaceutical products

Award method
Criterion:
Type: cost
Description: Arvioidun kokonaiskulutuksen yhteenlasketut kustannukset.
Weight (percentage, exact):
Estimated value
Not available
Final contracted value
6,000,000.00 EUR
Award of contract
Official name: Gilead Sciences Finland Oy
Postal address:
Town: Vantaa
Postal code: 01530
Country:
Documents
Prior information
Contract
Award
Footnote - legal notice

This content published on this page is meant purely as an additional service and has no legal effect. The Union's institutions do not assume any liability for its contents. The official versions of the relevant tendering notices are those published in the Supplement of Official Journal of the European Union and available in TED. Those official texts are directly accessible through the links embedded in this page. For more information please see Public Procurement Explainability and Liability notice.